Medicus Pharma Ltd. · NASDAQ:MDCX
Smith Andrew Alasdair received 735,294 Medicus Pharma Ltd. shares as an award (Form 4)
Traded Sep 4, 2026 · Filed Sep 8, 2026
On Sep 4, 2026, Smith Andrew Alasdair (Chief Operating Officer) received 735,294 Medicus Pharma Ltd. shares as an award at US$0.17 for US$125K, leaving 735,458 shares. Filed Sep 8, 2026 (Form 4).
- Awarded
- 735,294 shares
- Price
- US$0.17
- Value
- US$125K
- Holding after
- 735,458 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Shares, no par value | Award | 735,294 | US$0.17 | 735,458 | Direct |